-+ 0.00%
-+ 0.00%
-+ 0.00%
Sinqi Pharmaceutical (300573.SZ): Various products such as sodium hyaluronate eye drops are included in the national medical insurance catalogue
Share
Listen to the news

<国家基本医疗保险、生育保险和工伤保险药品目录><商业健康保险创新药品目录>Zhitong Finance App News, Xinqi Pharmaceutical (300573.SZ) issued an announcement. On November 14, 2026, the National Health Insurance Administration and the Ministry of Human Resources and Social Security issued the “Notice Concerning Issuance and (2026)” (Health Insurance Distribution (2026) No. 29). Currently, the company's 41 products continue to be included in the national health insurance catalogue, including 8 Class A and 33 Class B. Among them, various products such as ciclosporin eye drops (II) and sodium hyaluronate eye drops continued to be included in the “National Medical Insurance Catalogue”, and the compound electrolyte intraocular rinse was successfully retained in the national medical insurance catalogue.

This time, the company's product Shuanghuanglian Eye Drops was removed from the “National Medical Insurance Catalogue”. In recent years, this product has not involved production and sales, and its adjustments in the national medical insurance catalogue will not affect the company's business performance.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending